Service and Reimbursement Programs
Bristol-Myers Squibb Canada has implemented programs to help make our treatments accessible to patients.
ACCESS TO HOPE® Program
At Bristol-Myers Squibb we are proud of the contribution made by our Oncology Division which provides therapeutic options such as OPDIVO®, YERVOY®, and SPRYCEL® to patients living with cancer.
But we believe our responsibility to patients goes beyond treatment. We are committed to providing resources, information and support to patients who are prescribed our products.
With that in mind, we created the ACCESS TO HOPE® program which helps oncology patients by supporting access to their treatment. This program also offers comprehensive services and patient-friendly materials designed to meet individual patient needs.
We try to offer more than just treatment. We want to help oncology patients everyday…
For more information, call the ACCESS TO HOPE Program at: 1-877-967-6626 (toll-free).
ORENCIA RESPONSE PROGRAM®
The ORENCIA RESPONSE PROGRAM® was established by Bristol-Myers Squibb Canada to help make ORENCIA® (abatacept) treatment accessible to patients. If you have been prescribed ORENCIA, the program will assist you through the reimbursement process.
For more information, call the ORENCIA RESPONSE PROGRAM at: 1-877-979-3200 (toll-free).